Hamilton Thomas Edward's Form 4 filing
Larimar Therapeutics, Inc. (LRMR) · filed May 31, 2024
- Accession no.
- 0001062993-24-011568
- Filed
- May 31, 2024
- Trade date
- Feb 16-May 29, 2024
- Filing delay
- 105 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $500.0K. It was filed 105 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hamilton Thomas EdwardCIK 0001769848 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2024 | Common Stock | PPurchaseAcquired | +57,208 | $8.74 | +$499,997.92 | 564,798 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 29, 2024 | Common Stock | AGrant or awardAcquired | +19,000 | $0.00 | $0 | 19,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.